LAUSR

S., Saliba, J., Mouton, C., Leroy, E., Harutyunyan, A.S., Abgrall, J.-F., Favier, R., Toussaint, A., Solary, E., Kralovics, R., Constantinescu, S.N., Najman, A., Vainchenker, W., Plo, I. & Bellann eChantelot, C. (2014) Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors. Blood, 123, 1372– 1383. Mead, A.J., Rugless, M.J., Jacobsen, S.E.W. & Schuh, A. (2012) Germline JAK2 mutation in a family with hereditary thrombocytosis. The New England Journal of Medicine, 366, 967–969. Mead, A.J., Chowdhury, O., Pecquet, C., Dusa, A., Woll, P., Atkinson, D., Burns, A., Score, J., Rugless, M., Clifford, R., Moule, S., Bienz, N., Vyas, P., Cross, N., Gale, R.E., Henderson, S., Constantinescu, S.N., Schuh, A. & Jacobsen, S.E. (2013) Impact of isolated germline JAK2V617I mutation on human hematopoiesis. Blood, 121, 4156–4165.